Confidence interval estimation for number of patient-years needed to treat.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 403, doi. 10.1002/pst.1650
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2014 AND VI 13 AND IP 6
Results: 9
1
2
Adaptive graph-based multiple testing procedures.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 345, doi. 10.1002/pst.1640
- By:
- Publication type:
- Article
3
An efficient analysis of covariance model for crossover thorough QT studies with period-specific pre-dose baselines.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 388, doi. 10.1002/pst.1647
- By:
- Publication type:
- Article
4
Multiplicity and replicability: two sides of the same coin.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 343, doi. 10.1002/pst.1648
- By:
- Publication type:
- Article
5
Control of type 1 error in a hybrid complete two-period vaccine efficacy trial.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 397, doi. 10.1002/pst.1649
- By:
- Publication type:
- Article
6
Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer data.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 357, doi. 10.1002/pst.1630
- By:
- Publication type:
- Article
7
Fitting Emax models to clinical trial dose-response data when the high dose asymptote is ill defined.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 364, doi. 10.1002/pst.1636
- By:
- Publication type:
- Article
8
A recommended analysis for 2 × 2 crossover trials with baseline measurements.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 376, doi. 10.1002/pst.1638
- By:
- Publication type:
- Article
9
A note regarding meta-analysis of sequential trials with stopping for efficacy.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 6, p. 371, doi. 10.1002/pst.1639
- By:
- Publication type:
- Article